Agenus | Omsætningsaktiver

Current Assets Lave om Dato
AbbVie USD 33.22B 4.37B 2023-09
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Celldex Therapeutics USD 431.69M 185.76M 2023-12
CSL USD 9.26B 342.6M 2023-06
Dynavax Technologies USD 859.12M 23.45M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Incyte USD 4.65B 242.74M 2023-12
Merck EUR 13.57B 547M 2023-09
Merck USD 31.95B 1.98B 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Veracyte USD 285.62M 14.46M 2023-12



Agenus Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.